Pre-administration of BAX-inhibiting peptides decrease the loss of the nigral dopaminergic neurons in rats
- 1 January 2016
- journal article
- Published by Elsevier BV in Life Sciences
- Vol. 144, 113-120
- https://doi.org/10.1016/j.lfs.2015.11.019
Abstract
No abstract availableKeywords
Funding Information
- Education Department of Heilongjiang Province (1155h005)
- Scientific Research Fund of the First Affiliated Hospital of Harbin Medical University (R08-002)
This publication has 36 references indexed in Scilit:
- Dissociation of Progressive Dopaminergic Neuronal Death and Behavioral Impairments by Bax Deletion in a Mouse Model of Parkinson's DiseasesPLOS ONE, 2011
- Apoptosis-inducing factor mediates dopaminergic cell death in response to LPS-induced inflammatory stimulus: Evidence in Parkinson's disease patientsNeurobiology of Disease, 2011
- Apoptosis in Parkinson's disease: Signals for neuronal degradationAnnals of Neurology, 2003
- Is Bax a mitochondrial mediator in apoptotic death of dopaminergic neurons in Parkinson's disease?Journal of Neurochemistry, 2001
- Essential role of the mitochondrial apoptosis-inducing factor in programmed cell deathNature, 2001
- Bax ablation prevents dopaminergic neurodegeneration in the 1-methyl- 4-phenyl-1,2,3,6-tetrahydropyridine mouse model of Parkinson's diseaseProceedings of the National Academy of Sciences of the United States of America, 2001
- Increased Caspase 3 and Bax Immunoreactivity Accompany Nuclear GAPDH Translocation and Neuronal Apoptosis in Parkinson's DiseaseExperimental Neurology, 2000
- Mitochondrio‐nuclear translocation of AIF in apoptosis and necrosisThe FASEB Journal, 2000
- Molecular characterization of mitochondrial apoptosis-inducing factorNature, 1999
- Nigral degeneration in parkinson's diseaseMovement Disorders, 1993